The U.S. Supreme Court heard oral arguments today in two cases that are challenging the so-called Chevron deference doctrine, which says courts should defer to administrative agencies’ interpretation of the statutes delegated to them when there is an ambiguity.
2024 forecast: Biden admin efforts show there s no pricing relief on the horizon for pharma fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
The drug industry is launching a legal assault on Medicare’s new powers to negotiate drug prices just as talks with manufacturers begin, threatening to stall a key Biden initiative. Merck & Co., the U.S. Chamber of Commerce and Bristol Myers Squibb have all filed lawsuits against the Biden administration, seeking to block the Medicare price…